| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| GTO ID | GTC0919 |
| Trial ID | ChiCTR2100043739 |
| Disease | Lung Cancer | Esophageal Cancer | Colorectal Cancer |
| Altered gene | CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD276 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Phase I exploratory clinical study of CD276-targeted chimeric antigen receptor T cells for the treatment of solid tumors |
| Year | 2021 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Zhengzhou University |
| Cohort 1 | |||||||
|
|||||||